Cure HHT
EIN: 22-3115041 · Monkton, MD
About Cure HHT
Cure HHT was founded in 1991 with a mission to find a cure for Hereditary Hemorrhagic Telangiectasia (HHT), a genetic blood vessel disorder affecting over 1.4 million people worldwide. The organization is committed to raising awareness, improving treatments, and increasing patient access to life-saving care through education and research.
Impact of Cure HHT
Since 2003, Cure HHT has invested over $51.3 million in HHT research, funding numerous seed grants and leveraging additional investments to drive scientific progress and improve patient outcomes.
Why Donate?
Your donation to Cure HHT supports critical research and advocacy efforts aimed at improving the lives of individuals affected by HHT, ultimately working towards finding a cure for this often misdiagnosed condition.
Get Involved
Join the fight against HHT by donating today! Your contribution, whether in cryptocurrency or cash, can make a significant difference in the lives of those affected by this condition. Together, we can work towards a future without HHT.
Do you represent Cure HHT? Sign up and claim this page to customize it and gain access to our dashboard. Learn More.